CD20 Positive Non Hodgkin Lymphoma
3 clinical trials · Condition
◉ Watch CD20 Positive Non Hodgkin Lymphoma
| Record | Firm | Date |
|---|---|---|
| Dose Escalation and Expansion Study of CPO107 for Patients With Advanced CD20-positive Non-Hodgkins Lymphoma (NCT04853329) | Conjupro Biotherapeutics, Inc. | 2021-12-13 |
| Safety and Efficacy of EX103 in Subjects with Relapsed/Refractory CD20-Positive Non-Hodgkin Lymphoma (NCT06021678) | Guangzhou Excelmab Inc. | 2021-11-12 |
| Rituximab Plus MG4101 Indolent CD20-positive Non-Hodgkin Lymphoma (NHL) (NCT03578198) | Seoul National University Hospital | 2018-11-08 |
Track CD20 Positive Non Hodgkin Lymphoma automatically
Every clearance here is in the API, with alerts when new ones post.